# Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Saddle Block

> **NCT06216197** · NA · COMPLETED · sponsor: **Zulekha Hospitals** · enrollment: 58 (actual)

## Conditions studied

- Regional Anesthesia Morbidity

## Interventions

- **DRUG:** FENT group
- **DRUG:** DEX group

## Key facts

- **NCT ID:** NCT06216197
- **Lead sponsor:** Zulekha Hospitals
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-03
- **Primary completion:** 2022-12-04
- **Final completion:** 2022-12-04
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06216197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06216197, "Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Saddle Block". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06216197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*